Camsing Healthcare Limited Announces Issuance and Listing of 50 Million Conversion Shares Following Full Bond Conversion
Key Highlights from the Latest Corporate Announcement
- Full Conversion of Bonds: All outstanding Bonds of Camsing Healthcare Limited have been fully converted into new ordinary shares.
- Issuance of 50,000,000 New Shares: On 8 May 2026, the Company allotted and issued 50 million Conversion Shares at a price of S\$0.050 per share to Investors.
- Significant Expansion of Share Capital: The total issued share capital increased substantially from 90,000,000 to 140,000,000 shares.
- Listing Date for New Shares: The 50 million Conversion Shares are expected to begin trading on the Mainboard of the Singapore Exchange (SGX-ST) at 9:00 a.m. on or around 11 May 2026.
Details Investors Should Note
The Board of Directors of Camsing Healthcare Limited has confirmed that all Bonds have been fully converted as of 8 May 2026. This follows a sequence of key corporate actions and shareholder approvals since June 2023, culminating in the receipt of conversion notices on 9 April 2026. The new shares were issued to Investors according to the terms of the Bonds.
The Conversion Shares rank pari passu with existing ordinary shares in all respects. However, investors should note that these new shares do not qualify for any dividends, rights, allotments or other distributions declared with a record date on or before the date of issue of the Conversion Shares.
Potential Price-Sensitive and Shareholder-Relevant Information
- Substantial Increase in Share Capital: The number of shares in issue has increased by over 55%. This dilution could affect earnings per share (EPS) and may impact the share price depending on how the market perceives the utilisation of the new capital.
- Full Conversion of Outstanding Bonds: The company no longer has any outstanding Bonds, reducing its leverage and potentially strengthening its balance sheet. This could be viewed positively or negatively depending on investor preference for capital structure.
- New Shares Trading Date: The 50 million new shares are expected to commence trading on 11 May 2026. Investors may anticipate increased liquidity and potential volatility around this date.
- Dividend Eligibility: New Conversion Shares do not participate in dividends or distributions declared with a record date on or before their issuance. This is important for short-term dividend-focused investors.
Corporate Governance and Shareholder Approvals
The announcement follows a series of related disclosures and corporate actions, including an extraordinary general meeting and approvals related to the New Investment. These steps demonstrate transparency and adherence to regulatory requirements, which may enhance investor confidence.
Cautionary Note to Shareholders
The Company has advised shareholders to exercise caution when dealing in its shares. Those uncertain about the implications are encouraged to seek advice from their professional advisors.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors are advised to consult their stockbrokers, bank managers, solicitors, accountants, or other professional advisors before making any investment decisions.
